EMEA-000734-PIP01-09

Key facts

Active substance
[(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl) propoxy] biphenyl-3-yl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid hydrate (TAK-875)
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/243/2010
PIP number
EMEA-000734-PIP01-09
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Takeda Global Research and Development Centre (Europe) Ltd.
paediatrics@tgrd.com
Phone: +44 2031168237
Fax: +44 2031168250
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating